Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Completed 56Recruiting 19Unknown 18Terminated 8Active not recruiting 7Withdrawn 5Not yet recruiting 4No longer available 1Enrolling by invitation 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Classical hematology 1

Conditions

Breast Neoplasms 438Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 176Colorectal Neoplasms 158Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 131Lymphoma 128Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Head and Neck Neoplasms 101Brain Neoplasms 101Recurrence 100Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 75Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Interventions

veliparib 1bavituximab 1avatrombopag 1Sorafenib 1Radiotherapy 1Radiosurgery 1Paclitaxel 1Immunotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × Liver Diseases × Clear all
NCT05817994 2024-11-19

REGAL

Sheikh Shakhbout Medical City

Withdrawn
Gastrointestinal

Hepatitis, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure, Acute

NCT05084456 2021-10-19

Oral Docetaxel in Patients With Normal or Impaired Liver Function

Modra Pharmaceuticals

Phase 1 Withdrawn

Liver Diseases

NCT04437953 2020-12-08

Avatrombopag for Thrombocytopenia in People With Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Withdrawn
Classical hematology

Liver Diseases, Neoplasms, Thrombocytopenia

NCT02989870 2020-06-05

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT01419548 2017-07-02

ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn

Liver Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡